Zobrazeno 1 - 10
of 322
pro vyhledávání: '"M, Di Giacomo"'
Autor:
A. K. Orduz, M. Di Giacomo, R. Ferdinand, B. Jacquot, O. Kamalou, J-M. Lagniel, G. Normand, A. Savalle, D. Uriot
Publikováno v:
Physical Review Accelerators and Beams, Vol 25, Iss 6, p 060101 (2022)
SPIRAL2 is a high power linear accelerator part of the GANIL laboratory. This superconducting (SC) linac can accelerate cw light ions to heavy ions at energies up to 40 MeV/nucleon and 14.5 MeV/nucleon, respectively. In July 2019, the authorization t
Externí odkaz:
https://doaj.org/article/e4dcd16901a84ea481acaaaa103d1915
Autor:
N. Jacquelot, M. P. Roberti, D. P. Enot, S. Rusakiewicz, N. Ternès, S. Jegou, D. M. Woods, A. L. Sodré, M. Hansen, Y. Meirow, M. Sade-Feldman, A. Burra, S. S. Kwek, C. Flament, M. Messaoudene, C. P. M. Duong, L. Chen, B. S. Kwon, A. C. Anderson, V. K. Kuchroo, B. Weide, F. Aubin, C. Borg, S. Dalle, O. Beatrix, M. Ayyoub, B. Balme, G. Tomasic, A. M. Di Giacomo, M. Maio, D. Schadendorf, I. Melero, B. Dréno, A. Khammari, R. Dummer, M. Levesque, Y. Koguchi, L. Fong, M. Lotem, M. Baniyash, H. Schmidt, I. M. Svane, G. Kroemer, A. Marabelle, S. Michiels, A. Cavalcanti, M. J. Smyth, J. S. Weber, A. M. Eggermont, L. Zitvogel
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
The clinical management of metastatic melanoma requires predictors of the response to checkpoint blockade. Here, the authors use immunological assays to identify potential prognostic/predictive biomarkers in circulating blood cells and in tumor-infil
Externí odkaz:
https://doaj.org/article/807762e56e0f4dbf9806c82c666da282
Autor:
Anna M. Di Giacomo, Gianluca Giacobini, Gabriele Anichini, Claudia Gandolfo, Vincenzo D'alonzo, Luana Calabrò, Maria F. Lofiego, Maria G. Cusi, Michele Maio
Publikováno v:
European Journal of Cancer. 171:143-149
The protective role against SARS-CoV-2 infection by the third booster dose of mRNA vaccines in cancer patients with solid malignancies is presently unknown. We prospectively investigated the occurrence of COVID-19 in cancer patients on active therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d40c7ecc67a1074b0a0c8c7a7e5bf5
https://doi.org/10.1016/j.ejca.2022.05.018
https://doi.org/10.1016/j.ejca.2022.05.018
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anna M. Di Giacomo, Maximilian J. Mair, Michele Ceccarelli, Andrea Anichini, Ramy Ibrahim, Michael Weller, Michael Lahn, Alexander M.M. Eggermont, Bernard Fox, Michele Maio
During the V Siena Immuno-Oncology (IO) Think Tank meeting in 2021, conditions were discussed which favor immunotherapy responses in either primary or secondary brain malignancies. Core elements of these discussions have been reinforced by important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7423bf39cd2f63d5f0aa338b2777a1db
Autor:
Oliver J. Kennedy, Michal Kicinski, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger Koornstra, Leonel Hernandez-Aya, Anna M. Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Caroline Robert, Alexander M.M. Eggermont, Paul Lorigan, Mario Mandala
Publikováno v:
European Journal of Cancer, 165, 97-112
European Journal of Cancer, 165, pp. 97-112
Kennedy, O J, Kicinski, M, Valpione, S, Gandini, S, Suciu, S, Blank, C U, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, van Akkooi, A C J, Robert, C, Eggermont, A M M, Lorigan, P & Mandala, M 2022, ' Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 165, pp. 97-112 . https://doi.org/10.1016/j.ejca.2022.01.017
European Journal of Cancer, 165, pp. 97-112
Kennedy, O J, Kicinski, M, Valpione, S, Gandini, S, Suciu, S, Blank, C U, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, van Akkooi, A C J, Robert, C, Eggermont, A M M, Lorigan, P & Mandala, M 2022, ' Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 165, pp. 97-112 . https://doi.org/10.1016/j.ejca.2022.01.017
Background: β-adrenergic receptors are upregulated in melanoma cells and contribute to an immunosuppressive, pro-tumorigenic microenvironment. This study investigated the prognostic and predictive value of β-adrenoreceptor blockade by β-blockers i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75ba607dbd7225632c8df9aab98b7d3
http://hdl.handle.net/2066/250190
http://hdl.handle.net/2066/250190
Autor:
Anna M. Di Giacomo, Andrea Guarnieri, Sergio A. Tripodi, Marta Maccari, Nicoletta Mancianti, Garosi Guido, Giulia Rossi, Maria Grazia Daffinà, Luana Calabrò, Monica Valente, Michele Maio
Immune-related nephrotoxicity (ir-N) is a rare adverse event of immune-checkpoint(s) inhibitors (ICI) therapy and its clinical management is still debated. Among 501 consecutive ICI-treated patients at our Institution, 6 who developed an ir-N with cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a29efc5b89d39d254be252b88db796
https://hdl.handle.net/11365/1214174
https://hdl.handle.net/11365/1214174
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Bone & Joint Journal. :162-169
AimsMany authors have reported a shorter treatment time when using trifocal bone transport (TFT) rather than bifocal bone transport (BFT) in the management of long segmental tibial bone defects. However, the difference in the incidence of additional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3fd08e88d93b34b5ebb69251d739ca3
https://doi.org/10.1302/0301-620x.101b2.bjj-2018-0340.r2
https://doi.org/10.1302/0301-620x.101b2.bjj-2018-0340.r2